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Background: Pancreatic amyloid has been associated with type II diabetes. The
major constituent of pancreatic amyloid is the 37-residue peptide islet amyloid
polypeptide (IAPP). IAPP is expressed as a 67-residue pro-peptide called
ProIAPP which is processed to IAPP following stimulation. While the molecular
events underlying IAPP amyloid formation in vitro have been studied, little is
known about the role of ProIAPP in the formation of pancreatic amyloid. This has
been due in part to the limited availability of puri¢ed ProIAPP for conformational
and biochemical studies.
Results: We present a method for ef¢cient recombinant expression and
puri¢cation of ProIAPP and a processing site mutant, mutProIAPP, as thioredoxin
(Trx) fusion proteins. Conformation and amyloidogenicity of cleaved ProIAPP and
mutProIAPP and the fusion proteins were assessed by circular dichroism,
electron microscopy and Congo red staining. We ¢nd that ProIAPP and
mutProIAPP exhibit strong self-association potentials and are capable of forming
amyloid. However, the conformational transitions of ProIAPP and mutProIAPP
during aging and amyloidogenesis are distinct from the random coil-to-L-sheet
transition of IAPP. Both proteins are found to be less amyloidogenic than IAPP
and besides ¢brils a number of non-¢brillar but ordered aggregates form during
aging of ProIAPP. ProIAPP aggregates are cytotoxic on pancreatic cells but less
cytotoxic than IAPP while mutProIAPP aggregates essentially lack cytotoxicity.
The Trx fusion proteins are neither amyloidogenic nor cytotoxic.
Conclusions: Our studies suggest that ProIAPP has typical properties of an
amyloidogenic polypeptide but also indicate that the pro-region suppresses the
amyloidogenic and cytotoxic potentials of IAPP.
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Introduction
Pancreatic islet amyloid is found in more than 95% of type
II diabetes patients and is believed to be associated with
the pathologic sequelae of the disease [1^3]. Islet amyloid
consists predominantly of insoluble aggregates that are de-
rived from islet amyloid polypeptide (IAPP or amylin)
[1,4]. IAPP is a 37-amino acid residue peptide that is
mainly produced in pancreatic L-cells. Its soluble form
plays a role in glucose homeostasis, possibly as an insulin
counterregulatory hormone [5]. IAPP-derived amyloid ag-
gregates, however, are strongly cytotoxic to a variety of
cells, including L-cells [6,7].
IAPP is among the most amyloidogenic polypeptides
known [8^13]. The molecular cause of IAPP ¢brillization
is not yet known. However, as to the in vitro mechanism of
amyloidogenesis, it appears that IAPP follows kinetics that
are consistent with the nucleation-dependent polymeriza-
tion mechanism [12^14].
IAPP is expressed as an 89-amino acid precursor protein
(preProIAPP). Cleavage of the N-terminal signal peptide
yields ProIAPP, a 67-residue protein that contains the 37-
amino acid IAPP sequence £anked by 11- and 19-amino
acid N- and C-terminal pro-sequences, respectively [15]
(Figure 1A). IAPP is derived from ProIAPP by post-trans-
lational processing in the secretory granules of pancreatic
L-cells and is likely co-secreted with insulin into the cir-
culation in response to insulin secretagogues [15].
The role of ProIAPP and its processing in the formation of
pancreatic amyloid in vivo is poorly understood. Recent
studies have suggested that ProIAPP is processed by the
prohormone convertase PC2 which also is involved in the
processing of proinsulin and that abnormal processing of
ProIAPP may contribute to an IAPP-based amyloidosis
[16]. If, for example, the rate of ProIAPP processing in-
creased, higher concentrations of the strongly amyloido-
genic IAPP would accumulate that could then lead to an
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increase in amyloid deposit [17]. Conversely, if the rate of
ProIAPP processing slowed down or was incomplete, in-
creased amounts of ProIAPP would accumulate. The result
of the latter scenario cannot be predicted currently, be-
cause it is not known if ProIAPP is amyloidogenic and
cytotoxic per se. There have been no reports about the
molecular and conformational properties of ProIAPP. This
is due in part to the current lack of ef¢cient procedures for
a recombinant or synthetic generation of ProIAPP in
amounts suf¢cient for such studies. There are a number
of experimental dif¢culties expected to be encountered
during ProIAPP generation. These are either pertinent to
the chemical synthesis or recombinant expression and pu-
ri¢cation of amyloidogenic proteins or speci¢c to the strong
amyloidogenicity of IAPP [10,13,18,19].
We devised a method for the ef¢cient recombinant expres-
sion of ProIAPP as thioredoxin (Trx) fusion protein in
Escherichia coli in combination with a His-Tag-based and
high performance liquid chromatography (HPLC) puri¢ca-
tion procedure. This method enables pure ProIAPP to be
obtained for the ¢rst time in preparative amounts. In addi-
tion, a ProIAPP processing site mutant protein, mut-
ProIAPP, with each of the two Lys^Arg proteinase cleavage
sites of ProIAPP (Lys10^Arg11 and Lys50^Arg51 (Figure
1A)) substituted for Ala^Ala was designed and expressed
using an identical approach. The substitutions were
expected to render the mutProIAPP molecule resistant
to processing in a bioassay setting. We subsequently
performed studies on the solution conformation and puta-
tive amyloidogenic and cytotoxic potential of ProIAPP,
mutProIAPP and their fusion constructs using a variety
of biochemical methods including the Congo red (CR)
staining method, electron microscopy (EM), circular di-
Figure 1. Schematic representation of the
sequence and fusion construct of ProIAPP.
(A) cDNA and amino acid sequence of
preProIAPP, ProIAPP and IAPP. The
signal sequence and the N- and C-terminal
pro-regions are indicated. Upper lines
represent nucleotides and lower lines are
the corresponding amino acids. Numbers
indicate the translational start site (1), the
signal sequence cleavage site (22), and
the N- (34) and C-terminal (72) pro-region
cleavage sites. (B) Scheme of the fusion
constructs expressed. The ProIAPP or
mutProIAPP cDNA was fused C-terminally
to the tag region of the vector. The Ek
cleavage site for removal of the tag is
indicated. The S-Tag was not utilized in
this study. The fusion constructs have a
size of about 24.5 kDa; the tag region
corresponds to a size of 17 kDa; and
ProIAPP or mutProIAPP are about 7.5 kDa
in size.
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chroism spectropolarimetry (CD), and a cellular toxicity
assay.
Results
Design, expression, and puri¢cation of recombinant
ProIAPP and mutProIAPP
We used the E. coli BL21(DE3)pLysS-pET vector over-
expression system to produce ProIAPP and mutProIAPP.
This system has previously been demonstrated to ef¢-
ciently suppress unwanted expression activity of poten-
tially toxic proteins [20]. Cloning strategies were designed
for the expression of both ProIAPP alone and the Trx^
ProIAPP fusion protein. Identical strategies were applied
to mutProIAPP and the Trx^mutProIAPP fusion protein.
The testing of mutProIAPP was thought to provide infor-
mation about the proteolytic stability of ProIAPP to the
proinsulin- and proIAPP-processing endopeptidases when
incubated with RIN5fm cells [16,21^23]. These enzymes
might possibly process exogeneously applied ProIAPP into
IAPP during the 24-h incubation period of the cellular
assay and following ¢bril/aggregate-mediated disruption
of the cell membrane [24,25]. As the mutant protein would
not be processed to IAPP, its application was predicted to
be useful in distinguishing ProIAPP- from IAPP-mediated
effects. However, we also noted that the Lys^Arg-to-Ala^
Ala substitution resulted in a signi¢cant enhancement of
hydrophobicity of both the N-terminal sequence up to res-
idue Ala16 and the C-terminal sequence (45^56) according
to hydrophobicity analysis by the method of Kyte and
Doolittle [26] (data not shown).
Trx has previously been used successfully as a fusion moi-
ety to recombinantly express insoluble proteins in E. coli
[27]. For convenient puri¢cation of the fusion protein, an
additional His-Tag was included (Figure 1B). The fusion
tag could be removed by enterokinase (Ek) cleavage close
to the N-terminal Thr residue of the pro-sequence, result-
ing in wild type (wt) ProIAPP or mutProIAPP except for
one additional N-terminal Ile residue. The fusion proteins
Trx^ProIAPP and Trx^mutProIAPP were ef¢ciently ex-
pressed when bacterial cultures were induced with 1 mM
isopropyl-1-thio-L-D-galactopyranoside (IPTG) for 3 h (Fig-
ures 2A and 3A). Of note, the fusion proteins accounted for
an estimated 25% of total bacterial protein. By contrast,
expression of the ProIAPP- and mutProIAPP-alone con-
structs did not result in detectable target protein (data
not shown). Thus, this approach was not pursued further.
Both fusion proteins partitioned with the insoluble lysate
fraction and formed inclusion bodies. Inclusion bodies
were solubilized in 6 M urea (Figures 2A,B and 3A,B)
and fusion proteins were then puri¢ed by ion metal af¢nity
chromatography (IMAC) under denaturing, i.e. urea-con-
taining, conditions (Figure 2A). IMAC eluates from both
fusion proteins were approximately 80% pure (Figure 2A)
and were further puri¢ed to homogeneity by reverse phase
(RP)-HPLC on a C18-column. After this step, the Trx fu-
sion proteins which eluted within sharp peaks at about 24
min were judged as highly homogeneous on the basis of
their sodium dodecyl sulfate^polyacrylamide gel electro-
phoresis (SDS^PAGE) (Figure 2F) and HPLC pro¢les
(Figures 2C and 3C). HPLC-puri¢ed fusion proteins
were further characterized by matrix-assisted laser desorp-
tion ionization^time-of-£ight^mass spectroscopy (MALDI-
TOF-MS) which con¢rmed their identity and high grade
of purity. The MS data suggested that the applied expres-
sion system produced the fusion proteins both in an un-
processed form and with the N-terminal Met-residue
cleaved. Cleavage of the N-terminal Met was mainly de-
pendent on the induction conditions, i.e. length of bacte-
rial growth and IPTG concentration. For fusion proteins
without Met, the following masses were determined:
Trx^ProIAPP, 24 456 þ 24 Da (M+H) compared to an ex-
pected mass (M+H) of 24 430 Da; Trx^mutProIAPP,
24 125 þ 24 Da (M+H) compared to a theoretical mass
(M+H) of 24 145 Da. For protein species with the Met
residue included, representative masses for several prepa-
rations were: Trx^ProIAPP, 24 601 þ 25 Da (M+H) and
Trx^mutProIAPP, 24 238 þ 48 Da (M+H) compared to
the expected values of 24 561 Da (M+H) and 24 276 Da
(M+H), respectively.
Ek cleavage of Trx^ProIAPP resulted in an SDS^PAGE
electropherogram with a total of six detectable bands,
likely representing residual uncleaved fusion protein, the
cleaved Trx-Tag, monomeric ProIAPP, and also dimeric,
trimeric and multimeric ProIAPP self-assemblies (Figure
2A). This notion was con¢rmed by HPLC and mass spec-
troscopy (MS) analysis of the Ek digests (Figure 2D).
Although unexpected at ¢rst sight, stable non-covalent
oligomer formation even under SDS-based denaturing con-
ditions has often been observed for amyloid polypeptides
[12,28]. Consistent with the notion that stable oligomeriza-
tion of ProIAPP had occurred, was the ¢nding that the
cleaved Trx-Tag band (identity con¢rmed by MS at a
mass of 17 069 þ 17 Da (M+H); expected: (M+H) of
17 045 Da) was much stronger than any single ProIAPP
band, in particular the presumed monomer band. Togeth-
er, these observations already argued that ProIAPP had a
strong tendency to self-assemble into oligomers.
Digests were then subjected to C18-HPLC puri¢cation
(Figure 2D). Cleaved ProIAPP was well separated from
both the remaining uncleaved fusion protein and the
Trx-Tag and was isolated and lyophilized (Figure 2D).
SDS^PAGE and MS analysis of the HPLC fractions (Fig-
ure 2F and data not shown, respectively) con¢rmed their
correct assignment. The high purity grade of HPLC-puri-
¢ed ProIAPP was further con¢rmed by HPLC and MS
(found (M+H): 7549 þ 8 Da; calculated: (M+H) 7517
Da). Of note, we were unable to detect monomeric
ProIAPP by SDS^PAGE when eluates of the HPLC puri-
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Figure 2. Expression and puri¢cation of
ProIAPP. (A) SDS^PAGE of the
expression, His-Tag-based puri¢cation and
Ek cleavage of the Trx^ProIAPP fusion
protein. The fusion protein was expressed
by bacterial overexpression and crude
lysates and processed preparations
electrophoresed in a 20% homogeneous
gel. Comparable protein quantities were
applied in each lane. A molecular weight
marker of the indicated size range was co-
analyzed (lanes 1 and 9). Lane 2:
uninduced control; lane 3: crude extract
from IPTG-induced culture; lane 4: soluble
fraction of the lysate; lanes 5 and 6: urea-
solubilized inclusion body fraction at a
protein quantity as in 4 and at a ¢ve-fold
higher amount; lanes 7 and 8: ¢rst and
second eluate fractions of His-Tag
chromatographic step; lane 10: Ek-digested
His-Tag column eluate; letters a^f indicate
the putative ProIAPP species identi¢ed
and correspond to a ProIAPP oligomer, the
uncleaved fusion protein, a ProIAPP trimer,
the Trx-tag, a ProIAPP dimer, and the
ProIAPP monomer, respectively. (B) RP-
HPLC chromatogram of a urea-solubilized
inclusion body fraction of Trx-ProIAPP (for
HPLC conditions, also for (C)^(E), see
Materials and Methods). The peak at 5^10
min is due to urea. (C) RP-HPLC
chromatogram of HPLC-puri¢ed Trx^
ProIAPP dissolved in 10% HAc. The peak
at 5^10 min is due to HAc. (D) RP-HPLC
chromatogram of an Ek-digested
preparation of HPLC-puri¢ed Trx^ProIAPP.
The identi¢ed polypeptide species are
indicated. (E) RP-HPLC chromatogram of
HPLC-puri¢ed ProIAPP dissolved in 10%
HAc. The peak at 5^10 min is due to HAc.
(F) SDS^PAGE of the HPLC-puri¢ed and
lyophilized fractions as recovered from (D).
The marker (lane 1) was as in (A). Lanes
2^4 represent the ProIAPP, fusion protein
and tag peaks, respectively.
CHBIOL 33 31-10-00 Cyaan Magenta Geel Zwart
858 Chemistry & Biology 2000, Vol 7 No 11
¢cations were directly subjected to SDS^PAGE analysis.
Instead, only bands likely corresponding to higher molec-
ular weight ProIAPP aggregates were obtained under these
conditions. However, ProIAPP in its monomeric form (see
Figure 2F), was always detected when the collected
HPLC fractions were immediately frozen and lyophilized
and then directly dissolved in the SDS sample buffer,
boiled and electrophoresed immediately. Similar observa-
tions were made during attempts to recover ProIAPP by
C18-HPLC, indicating a strong and time-dependent aggre-
gational potential for monomeric ProIAPP.
In summary, from 200 ml bacterial culture, 42 mg of total
bacterial lysate protein and 5 mg of pure Trx^ProIAPP
fusion protein were recovered, corresponding to an overall
yield of 12.5%. Following Ek cleavage, HPLC puri¢cation
yielded 0.9 mg of pure ProIAPP, which corresponded to a
Trx^ProIAPP cleavage and puri¢cation yield of 60%. It is
of note that the established recombinant procedure enables
the puri¢cation of several milligrams of pure Trx^ProIAPP
fusion protein and pure ProIAPP from a few liters of cul-
ture within 1 week.
Ek cleavage of HPLC-puri¢ed Trx^mutProIAPP (Figure
3C) proceeded essentially as described for the wt fusion
protein according to SDS^PAGE (data not shown), HPLC
(Figure 3D) and MS analyses of the digests. Following
HPLC puri¢cation of the digests, mutProIAPP of high
Figure 3. Expression and puri¢cation of
mutProIAPP (for conditions see Figure 2).
(A) SDS^PAGE (20% homogeneous gel)
of a Trx^mutProIAPP-containing inclusion
body fraction. Trx^mutProIAPP was
expressed and processed as for
Trx^ProIAPP (see legend of Figure 2A).
Left lane: A molecular weight marker of
the indicated size range was co-analyzed;
right lane: urea-solubilized inclusion body
fraction. (B) RP-HPLC chromatogram of
urea-solubilized inclusion bodies of
Trx^mutProIAPP. The S^S-dimeric
Trx^mutProIAPP adduct was identi¢ed by
MS (see Results). The peak between
5^10 min is due to urea. (C) RP-HPLC
chromatogram of HPLC-puri¢ed
Trx^mutProIAPP dissolved in 10% HAc.
The peak between 5^10 min is due to
HAc. (D) RP-HPLC chromatogram of an
Ek-digested preparation of HPLC-puri¢ed
Trx^mutProIAPP. The peak between
5^10 min is due to HAc. The identi¢ed
proteins as con¢rmed by MS are indicated.
The Trx-Tag has a nearly identical
retention time to Trx^mutProIAPP under
the applied HPLC conditions.
(E) RP-HPLC chromatogram of HPLC-
puri¢ed mutProIAPP dissolved in 10%
HAc. The peak between 5^12 min is due
to HAc.
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purity was obtained as con¢rmed by HPLC (Figure 3E)
and MS analysis of the HPLC-collected mutProIAPP peak
(found (M+H) mass: 7238 þ 7 Da; calculated (M+H)
mass: 7233 Da). All chromatographic puri¢cations of mut-
ProIAPP and its fusion protein led to reduced recovery
yields compared to the corresponding wt species. One rea-
son for this ¢nding appears to be the observed propensity
of Trx^mutProIAPP, solubilized from inclusion bodies by
aqueous 6 M urea, to oxidize into disul¢de-linked di- and
oligomers, even during storage at 320‡C in buffer contain-
ing 6 M urea (Figure 3B). The formation of such species
was derived from MS analyses of the corresponding HPLC
fractions (Figure 3B). Of note, formation of the disul¢de
species was reversible by treatment with dithiothreitol.
Trx-ProIAPP was also found to be prone to oxidation
under the above conditions, but to a lesser degree than
the mutant protein. In addition, increased adherence of
mutProIAPP-related proteins as compared to the
ProIAPP-derived species on the chromatographic support
was noted. This behavior could be due to the predicted
higher hydrophobicity of mutProIAPP (see above). Overall
and likely owing to the discussed effects, mutProIAPP
recovery from the last puri¢cation step was about 25% of
that obtained for ProIAPP.
Amyloidogenicity of ProIAPP, mutproIAPP and the fusion
proteins
We aged ProIAPP, mutProIAPP and the fusion proteins for
four days under the ¢brillogenic conditions previously es-
tablished for native-like amyloid formation by IAPP
[12,13,29]. The resulting solutions were then tested for
amyloidogenic properties.
Both Trx^ProIAPP and ProIAPP bound CR [30]. However,
only ProIAPP exhibited the green^yellow birefringence
(Figure 4A) that CR-treated amyloid structures, including
IAPP ¢brils [13], usually exhibit under polarized light [30].
MutProIAPP and Trx^mutProIAPP bound CR, but did not
show birefringence under polarized light (data not shown).
EM analysis revealed that aged ProIAPP solutions con-
sisted of ¢brils and ¢bril bundles with the typical morphol-
ogy of amyloid (Figure 4B). ProIAPP ¢brils had diameters
between 10 and 20 nm and consisted of at least two ¢la-
ments that coiled around each other, yielding ¢brils that
showed an axial helical periodicity [10,31,32]. Mutated
ProIAPP also formed ¢brils (Figure 4C). Compared to
ProIAPP, the ¢brils of the mutant protein formed a web-
like structure that was denser than that of ProIAPP, while
single ¢brils appeared to have diameters of the same order
as those of ProIAPP. Of importance, our ¢ndings indicated
that there are no marked differences between the morpho-
logical features of ProIAPP and IAPP ¢brils when prepared
under the same ¢bril-promoting conditions (Figure 4B,D).
However, IAPP ¢brils are usually visibly insoluble while
ProIAPP ¢brils were not visible to the eye, indicating that
higher-order ¢brillar aggregates form in the IAPP solution.
In addition, a number of the observed ProIAPP ¢brils were
shorter (average length of less than 700 nm) than usually
found IAPP ¢brils. Contrary to ProIAPP and mutProIAPP,
the Trx fusion proteins did not form ¢brils (Figure 4E).
Solution conformation of ProIAPP, mutProIAPP and the
fusion proteins as determined by CD spectroscopy
We next studied the conformation of the investigated pro-
teins in solution by far-UV CD spectropolarimetry. To be
able to study the solution conformation of a protein with
amyloidogenic potential, appropriate stock solutions that
keep the protein in a non-aggregated and denaturated state
are required [13,22,33,34]. 1,1,1,3,3,3-Hexa£uoro-2-propa-
nol (HFIP) is a commonly used solvent that keeps amy-
loidogenic polypeptides in a disaggregated and denatu-
rated state [13,33] and has been used previously by us to
prepare IAPP stocks [12,13]. Unfortunately, ProIAPP was
completely insoluble in HFIP. We thus applied 8 M urea
to prepare stocks of ProIAPP, mutProIAPP, and the fusion
proteins and found that these conditions kept the proteins
in a soluble and non-aggregated state (at 500 WM and
320‡C for several months). To compare the results of
these studies with the results of our previous studies on
IAPP [13] stocks of IAPP in 8 M urea were also prepared
and comparative CD experiments performed with IAPP
under the same buffer conditions as for the pro-proteins.
The need to use urea stocks for IAPP was accompanied by
several experimental dif¢culties. For example, like the pre-
viously investigated denaturant guanidine hydrochloride
(GdnHCl) [13], urea proved not to be an ideal denaturant
for IAPP. Variable lag times were obtained when IAPP
stocks in 8 M urea were used to prepare the CD solutions
which was in contrast to the recently reported measure-
ments using HFIP stocks [13]. Aggregational lag times
were found to depend on several factors, including the
‘age’ of the stock solution. This observation may be related
to the degree of unfolding caused by urea and a possible
stabilization of partially unfolded amyloidogenic popula-
tions as previously found to occur in GdnHCl solutions
[13]. This suggestion would be consistent with the ob-
served increased L-sheet contents of IAPP in the urea-con-
C
Figure 4. ProIAPP and mutProIAPP but not the corresponding fusion proteins are amyloidogenic. In (A) CR staining of aged ProIAPP is
shown: on the left, bright ¢eld microscopic examination; on the right microscopic examination under polarized light are shown. EM analysis
of negatively stained, aged solutions of ProIAPP (B), mutProIAPP (C), IAPP (D) and the Trx^ProIAPP fusion protein (E) are shown. EM
pictures of Trx^mutProIAPP preparations were identical to that shown in (E). All proteins were aged in 10% HAc as described in Materials
and Methods and analyses were performed with a protein working concentration of 1 mM. Size bars for the EM pictures are indicated.
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taining buffer as compared to HFIP conditions (see be-
low). More detailed investigations on the effect of urea
on IAPP unfolding and amyloidogenicity are needed but
are not the focus of this study.
We ¢rst con¢rmed that the denatured proteins immedi-
ately refolded upon 100-fold dilution of the denaturant
into the CD buffer [35]. Protein refolding was evident
from the lack of time-dependent changes in the CD spec-
tra for up to 5 h and was in agreement with the often
described rapid folding of polypeptides. We found no con-
centration dependence in the spectra of ProIAPP between
0.5 and 5 WM. This indicated that ProIAPP was predom-
inantly monomeric over this concentration range, at least
immediately following preparation of the solution. Self-as-
sembly was observed to occur only hours later (see below).
Spectra of ProIAPP and mutProIAPP were then recorded
at protein concentrations of 5 WM in 10 mM phosphate
buffer containing 0.08 M urea. Such a urea concentration
was unlikely to have an effect on protein conformation, as
no changes in the CD spectra were observed upon a 1/10
dilution of these solutions into phosphate buffer (resulting
urea concentration of 0.008 M). CD spectra of the fusion
proteins were measured at a protein concentration of 1 WM
and in the same buffer as above.
The CD spectrum of freshly reconstituted ProIAPP
showed a strong minimum at about 208 nm (Figure 5A),
indicating that the protein contained considerable portions
of both ordered and random coil structure. This result was
con¢rmed by multilinear regression analysis of the spectra
by using the Lincomb program [36] and the reference
Figure 5. Aging of the proteins as followed by CD spectroscopy. Far-UV CD spectra of freshly dissolved and aged ProIAPP (A),
mutProIAPP (B), IAPP (C), and the Trx^ProIAPP fusion protein (D). CD spectra were obtained at the indicated time points in protein
solutions containing 5 WM protein (1 WM in D) in 10 mM sodium phosphate buffer and 0.08 M urea, pH 7.4, as described in Materials and
Methods.
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spectra sets of Perczel et al. [36] and Brahms and Brahms
[37]. According to these analyses, folded ProIAPP con-
tained approximately 50% structured elements that con-
sisted of L-sheets and L-turns. Antiparallel L-sheet struc-
ture was the dominant (50%) structured element according
to the reference set of Perczel et al., while analysis by
Brahms and Brahms suggested the presence of both L-
sheets (30%) and L-turns (20%). Refolded mutProIAPP
had a very similar spectrum (Figure 5B) to that of ProIAPP,
indicating that the introduced mutations did not signi¢-
cantly affect the overall conformation of ProIAPP. It should
be noted that the set of Perczel et al. encompasses refer-
ence spectra for parallel L-sheets and also reference spectra
for antiparallel L-sheet structure [36,38]. By contrast, the
set of Brahms and Brahms cannot differentiate between
these two structures [37]. However, since the CD of L-
sheets may strongly vary depending on the various features
of the sheets [39], a distinction between the two types of
L-sheet structure should be interpreted with caution. The
spectrum of Trx^ProIAPP was similar to that of ProIAPP
(Figure 5D). Deconvolutions indicated that L-sheets and
L-turns were the predominant ordered elements in Trx^
ProIAPP (40^55%). The shape of the CD spectrum of
IAPP in the 0.08 M urea-containing buffer indicated the
presence of signi¢cant amounts of structured elements in
addition to the random coil component (Figure 5C). This
notion was con¢rmed by deconvolutions, which suggested
that the ensemble of conformations of IAPP consisted pre-
dominantly of L-sheets (40^50%), with about 50% of un-
ordered elements present.
We have recently reported that, at 45‡C, IAPP populates a
conformeric state that is able to immediately self-assemble
into L-sheets and insoluble amyloid [13]. Temperature-in-
duced denaturation of ProIAPP and mutProIAPP was thus
studied next. Interestingly, the overall conformations of
both ProIAPP and mutProIAPP were found to be essen-
tially independent of temperature (up to 95‡C). No evi-
dence was obtained that a speci¢c ProIAPP conformeric
state was populated in the temperature denaturation path-
way (data not shown) and no amyloid formation was ob-
served during denaturation of ProIAPP and mutProIAPP.
Aging of ProIAPP, mutProIAPP, and the fusion proteins as
followed by CD and EM
We applied far-UV CD in combination with EM and fol-
lowed the effect of ‘aging’ on ProIAPP, mutProIAPP and
fusion protein conformation and amyloidogenicity. For
comparison, ‘aging’ studies under the same conditions
were also performed for IAPP.
Freshly refolded aqueous protein solutions at 5 WM were
allowed to stand in the CD cell for several days at room
temperature (RT) and spectra were measured at various
time points [13] (Figure 5). The spectrum of ProIAPP
(Figure 5A) started to change 7 h following refolding.
This change was characterized by a red shift of the mini-
mum at 207 nm that reached 212 nm 3 days later and by a
dramatic (absolute) decrease of the magnitude of the over-
all CD signal. After four days, nearly no CD signal was
present in the aged ProIAPP solution. A nearly identical
conformational transition was seen during the aging process
of mutProIAPP (Figure 5B). The dramatic reduction in the
CD signal may have been due to protein precipitation or
adsorption by the glass surface of the quartz cell [12,40]. It
appears, however, that neither of these effects had ac-
counted for the observed changes. First, the absorbance
of the protein solution in the UV region (200^250 nm)
did not change during the time scale of the experiment.
Secondly, no turbidity, protein insolubilization, or precipi-
tation was noted during the experiments. Thirdly, no con-
centration effect was observed when ProIAPP was mea-
sured at a 10-fold lower concentration (0.5 WM), which
usually would be a characteristic feature of loss of CD
signal due to adsorption to the glass surface [40]. These
results suggested that the time-dependent changes in the
CD spectra of ProIAPP and mutProIAPP were due to real
aging-related conformational transitions. Such changes may
occur during ProIAPP or mutProIAPP oligo- and multime-
rization. This notion would be consistent with the obser-
vation that we were unable to detect reasonable amounts
of monomers of ProIAPP or mutProIAPP when the CD
solutions were subjected to SDS^PAGE (not shown).
CD time-dependence studies of IAPP were then per-
formed (Figure 5C). These data con¢rmed that also under
these conditions, IAPP aggregation into amyloid proceeded
via the recently described conformational transition into L-
sheets [13]. The transition started following a lag time that
varied from 0 to 18 h.
The spectra of the fusion proteins did not change over
time (Figure 5D) and monomers of these species were
readily detectable by SDS^PAGE, con¢rming that these
proteins had a strongly diminished self-association poten-
tial compared to ProIAPP or mutProIAPP.
The aged CD solutions were centrifuged and pellets ex-
amined by EM. ProIAPP pellets (after 5^6 days of aging)
were found to contain areas that consisted of either non-
¢brillar yet ordered self-assembled species (Figure 6A) or
of ¢brillar assemblies (Figure 6B). The non-¢brillar species
(Figure 6A) seemed to consist of at least all three pre¢bril-
lar oligo- and multimeric species that have recently been
described to appear early in the amyloidogenesis process of
K-synuclein and L-amyloid peptide (AL) [41^43]. The spe-
cies included: (a) spherical species, that have previously
been named ‘spheres’ (estimated diameters between 10
and 20 nm) and which seemed to be the basic units of
the observed ordered, non-¢brillar assemblies; (b) linear
assemblies that appeared to consist of a linear association
of ‘spheres’ and that could be identical to the so-called
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‘chains’ or ‘proto¢brils’ [41^43] and (c) ‘chains’, that ap-
peared circularized into the recently identi¢ed ‘rings’ [41]
and which were either elliptical or circular. Of note, assem-
blies of two-, four-, and six-‘ring’ structures that appeared
to be similar to the ‘loops’ recently reported to be present
in apolipoprotein C-II amyloid aggregates were also ob-
served [44]. The diameters of the circular assemblies
were estimated to be between 30 and 60 nm, while for
the elliptical structures, axes of about 40^60 nm by 70^
150 nm were estimated.
The ¢brillar assemblies found were not visible to the eye
and had similar diameters to ProIAPP ¢brils that were
observed when ¢brillogenic, high-concentration incubation
conditions were applied (Figure 4B). Fibrils were of vari-
ous lengths and partly assembled laterally into broad,
sheet-like arrays (Figure 6B). Several of the ¢brils inter-
twined at several cross-sections with others leading to an
extension of the ¢brillar array over several square micro-
meters (Figure 6B). These ¢brillar assemblies were differ-
ent from the typical ¢brillar bundles seen under ‘¢brillo-
genic’ conditions (Figures 4B and 6B).
Pellets of the CD incubations of mutProIAPP (incubated
for 5^6 days) also contained some transparent, sheet-like
¢brillar arrays which mainly consisted of laterally associated
¢brils (Figure 6C). Unlike for ProIAPP, major parts of the
grid were covered by amorphous aggregates.
Figure 6. Electron microscopic examination of the aggregates formed following aging of CD solutions of ProIAPP (A, B), mutProIAPP (C)
and IAPP (D). Protein concentrations were 5 WM in 10 mM phosphate buffer containing 0.08 M urea, pH 7.4. In (A), the ordered but non-
¢brillar ProIAPP aggregates are shown (arrows indicate `ring'-like structures) and in (B), ¢brillar ProIAPP aggregates are shown. The above
assemblies represent the main species present 5^6 days after the start of the incubation. In (C), ¢brillar mutProIAPP aggregates are
shown that represent the ¢brillar species that were present 5^6 days after the start of the incubation. Major parts of the grid were covered
by amorphous aggregates which are not shown. In (D), IAPP ¢brils that were representative of the ¢brillar species obtained 48 h following
the start of the incubation are shown. Note that aging of the protein preparations used, was followed up by CD prior to the EM analysis
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IAPP pellets obtained from the CD experiments following
the transition into L-sheets (Figure 5C) were also exam-
ined. These preparations mainly contained insoluble amy-
loid ¢brils and ¢brillar bundles of typical amyloid appear-
ance (Figure 6D) while proto¢brils [11,42] and ordered
oligomers were also present (Figure 6D).
Cytotoxicity of ProIAPP, mutProIAPP and the fusion
proteins on a pancreatic cell line
IAPP-derived amyloid is strongly cytotoxic to a variety of
cells, including pancreatic L-cells [6,22]. We compared the
potential cytotoxicity of aged ProIAPP and mutProIAPP
solutions with the cytotoxicity of IAPP on the pancreatic
cell line RIN5fm [6,21^23].
The aged stock solutions applied (2 mM protein in 10%
HAc, 4 days incubation followed by neutralization with
10% NH4OH) were analyzed by EM prior to the cellular
assay and were found to predominantly contain amyloid
¢brils (Figure 4B^D). Serial dilutions of these stocks
with cell medium were then made to obtain apparent pro-
tein concentrations from 1 WM to 10 nM. The term ‘ap-
parent concentration’ is an approximation and relates to the
molar concentrations of these proteins in a non-associated
state [22]. IAPP was cytotoxic with an obtained EC50 of
about 100 nM, while aged ProIAPP was also found to be
cytotoxic, but was about three-fold less toxic than IAPP
(EC50 of V300 nM) (Figure 7). Interestingly, aged mut-
ProIAPP solutions showed essentially no cytotoxic proper-
ties (Figure 7). The non-amyloidogenic fusion proteins
fully lacked cytotoxicity (data not shown).
Although the ¢brillar state of ProIAPP and mutProIAPP in
the stock solutions used to prepare the diluted samples
was demonstrated by EM (see Figure 4B,C), the compo-
sitions of their assembly states at the lower concentrations
as applied onto the cells were not known. Consistent with
previous ¢ndings [13], signi¢cant amounts of ¢brillar ag-
gregates were found in diluted IAPP solutions including
the 1 WM solution (not shown). However, EM examination
after 1 day of incubation of a 10 WM ProIAPP solution
(made by dilution into 10 mM phosphate buffer, pH 7.4,
of the ¢brils of the 2 mM ProIAPP incubation (see above))
failed to detect ¢brillar species while ordered, oligomeric
assemblies and amorphous aggregates were present. By
contrast, at 100 WM ProIAPP, sheet-like ¢brillar assemblies
(Figure 6B) were seen. In the case of diluted mutProIAPP
¢brils, mainly amorphous aggregates and some non-¢brillar,
ordered oligomers were detected at protein concentrations
equal to or less than 100 WM.
Discussion
We elected to generate human ProIAPP and mutProIAPP
by recombinant methods rather than chemical synthesis.
As the IAPP molecule is among the most amyloidogenic
peptides known, the chemical synthesis of ProIAPP by
methods of solid phase peptide synthesis (SPPS) was pre-
dicted to be dif¢cult [10,13,18,19,28]. Recombinant expres-
sion of polypeptides that, by length, are still within the
reach of SPPS methods have recently been applied more
widely, because ef¢cient recombinant expression systems
have become available [18,27,45]. Another reason for the
recombinant strategy chosen for this study was that we
wished to generate fusion proteins with the ProIAPP moi-
ety linked to a soluble protein tag that could serve to
enhance solubility [27,46].
The Trx-tagged fusion proteins were expressed success-
fully at good rates. Trx-based gene fusion expression sys-
tems have proven useful for the convenient expression and
puri¢cation of weakly soluble proteins [27,47]. There are
some examples of successful recombinant expression of an
amyloid polypeptide as fusion construct with a soluble
protein moiety. These include the expression of the AL
peptide as Trx^His-tagged fusion construct [18], the ex-
pression of the Ure2 prion domain (UPD) as glutathione-
S-transferase (GST)^UPD fusion protein [48], or the ex-
pression of the Huntington’s disease (HD) protein as
GST^HD exon 1 fusion protein [49,50]. Our study is the
¢rst example of recombinant expression of an IAPP-related
protein. As for the other reported examples, expression of
ProIAPP as a fusion construct together with a soluble moi-
ety offered several advantages. We obtained good expres-
sion rates (approximately 25%); the fusion protein parti-
tioned with the inclusion body fraction, but could be
solubilized and handled thereafter; and following cleavage,
Figure 7. Cytotoxicity potentials of ProIAPP and mutProIAPP in
comparison to IAPP. Aged protein solutions were added to
RIN5fm pancreatic islet cells at the indicated concentrations and
cell viability assessed by MTT reduction assay after a 20 h
incubation. Data are percentage values of control (vehicle alone;
100% viability) and represent the mean þ S.D. from 6^18
determinations.
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we obtained ProIAPP in reasonable amounts and good
purity. Most importantly, isolated ProIAPP exhibited prop-
erties that were, although distinct from IAPP, that of an
amyloidogenic polypeptide, demonstrating that the re-
combinant expression and reconstitution procedure al-
lowed for the properties of ProIAPP to be retained.
The Ek cleavage designed to proceed C-terminally of the
recognition sequence (Asp)4^Lys in Trx^ProIAPP and
Trx^mutProIAPP was generally found to be speci¢c. How-
ever, we occasionally observed formation of a non-speci¢c
cleavage product. According to MS analysis, this by-prod-
uct (amounting to 0^30% of ProIAPP or mutProIAPP
yield) corresponded to the sequence stretch [23^67], thus
likely having resulted from Ek cleavage at the Arg22^Leu23
amide bond of either protein. For the non-speci¢c cleavage
product of ProIAPP a (M+H) mass of 4914 þ 5 Da was
found (calculated (M+H) mass: 4921 Da) and for the
side-product of mutProIAPP a (M+H) mass of 4778 þ 5
Da was measured (calculated (M+H) mass: 4778 Da).
The similarity of sequence Asn21^Arg22^Leu23 to the Ek
cleavage recognition site (Asp)4^Lys^Ile might thus have
accounted for the observed non-speci¢c cleavage. Our cur-
rent data indicate that the non-speci¢c cleavage may have
been due to the use of an excess of Ek and prolonged
cleavage times that were occasionally applied to increase
the yields of ProIAPP or mutProIAPP.
Removal of the fusion protein moieties led to a dramatic
change in protein solubility as well as aggregational and
amyloidogenic potential (see below). ProIAPP and mut-
ProIAPP were found to aggregate into ¢brils of typical
amyloid morphology, when the amyloid-promoting condi-
tions were applied that have previously been used to gen-
erate native-like IAPP ¢brils [13,29]. Similar to IAPP ¢-
brils, ProIAPP ¢brils exhibited birefringence under
polarized light following staining with CR. By contrast,
mutProIAPP ¢brils did not show birefringence. The exact
mechanism of CR binding and birefringence of amyloido-
genic polypeptides is still unknown [34]. In addition, there
have been several reports about ¢brils of various proteins
that lack birefringence upon CR staining [51^53]. One
reason for the observed different CR behavior of ProIAPP
and mutProIAPP could lie within different ratios of ¢brillar
(which most probably are the birefringent species) to non-
¢brillar aggregates (which are usually not birefringent [54])
present in the CR incubations which may be caused by
differences in ¢brillar stability and ¢bril dissociation rates
into aggregates. This has been recently suggested to ac-
count for the reduced CR binding of AL proto¢brillar spe-
cies as compared to the corresponding ¢brils [54]. Here,
such a notion would be consistent with the results of the
dilution experiments which indicated a reduced stability
against the dissociation of the ¢brillar assemblies of mut-
ProIAPP as compared to ProIAPP and IAPP. Proto¢brillar
and other non-¢brillar species have been described to ex-
hibit different CR binding than ¢brils [54^56]. Also, differ-
ences between the amyloidogenic properties, morphologi-
cal features and the tinctorial properties of the protein
assembly forms have been reported to be caused even
by a single mutation in an amyloidogenic protein
[55,57,58].
In agreement with the observed good solubility and low
aggregational potencies, the Trx-tagged fusion proteins
were completely non-amyloidogenic, suggesting that intro-
duction of the tag had resulted in disruption of both the
self-association and amyloidogenic potentials of ProIAPP
and mutProIAPP. A similar effect has been described for
fusion moieties linked to other amyloid polypeptides [50].
The high portion of unordered elements (50%) seen for
ProIAPP suggested a high conformational £exibility of this
protein. This ¢nding and the observed stability to heat
denaturation were reminiscent of the reported £exibility
of certain other amyloidogenic proteins including K-synu-
clein [59,60] and gelsolin [61].
The observed absence of any effects of temperature on the
conformation and amyloidogenicity of ProIAPP indicated
that the presence of the pro-region may have resulted in
enhanced conformational stability compared to IAPP which
had previously been observed to aggregate into amyloid
¢brils at higher temperatures [13]. Also, unlike for IAPP
[13], no evidence for the existence or stabilization of a
speci¢c partly unfolded, amyloidogenic precursor popula-
tion was obtained for ProIAPP. The pro-region has been
suggested to be essential for and to assist in protein folding
for several proteins [62]. It has been proposed that pro-
sequences could act as direct catalysts of folding by in-
creasing the rate of on-pathway folding, acting to signi¢-
cantly decrease the life-time of protein folding intermedi-
ates and to result in a signi¢cant suppression of off-
pathway aggregation [62,63]. On the other hand, protein
aggregation and amyloid formation has been shown to pro-
ceed via partially folded states [64] and in vivo-formed
amyloid essentially consists of the mature (processed) pro-
tein sequences. Thus, it appeared reasonable to speculate
that the pro-region of an amyloidogenic polypeptide could
serve to protect the amyloidogenic peptide against ¢brillo-
genesis.
For several amyloidogenic polypeptides including AL,
prion protein, K-synuclein, and IAPP, it has been shown
that ¢bril formation occurs via a conformational transition
into L-sheet structures [13,65^67]. Our studies showed that
ProIAPP and mutProIAPP are able to aggregate into typi-
cal ¢brillar assemblies under strong amyloidogenic condi-
tions [12,13,29]. Under such amyloid-promoting conditions,
however, it is not possible to investigate early events of the
self-assembly pathway of ProIAPP and compare them with
the corresponding events previously observed to occur dur-
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ing IAPP amyloidogenesis [13]. By contrast, under the low-
concentration conditions that were used for the CD aging
experiments a direct follow-up of these events became
possible.
Consistent with our previous observations, aging of IAPP,
also when performed under the conditions applied herein
for ProIAPP, led to a time-dependent conformational tran-
sition into soluble L-sheets and amyloid [13]. By contrast,
aging, self-association and ¢bril formation of ProIAPP, pro-
ceeded via a distinct conformational transition that was
characterized by a dramatic absolute decrease of the neg-
ative CD of non-aggregated ProIAPP between 200 and 240
nm with a subsequent nearly complete disappearance of
the CD signal. MutProIAPP behaved like ProIAPP. None
of the spectra obtained during ProIAPP- or mutProIAPP-
aging exhibited the characteristic features of a transition
into L-sheet structures [39] and no differences were de-
tected between the secondary structure contents of the
spectra obtained during the aging process. However, as
the effect of size and quarternary structural rearrangement
of L-sheets on their far-UV CD signal is unknown and as
suitable reference spectra for stacked and multimeric L-
sheet structures as found in an amyloid ¢bril are not yet
available [39], the results of the visual or deconvolution-
based predictions of secondary structure contents of amy-
loid-forming polypeptides should be interpreted with cau-
tion. The observed decrease in magnitude of the CD sig-
nal may have been due to a gradual increase in the
corresponding positive CD signal in this region. Such a
change of CD signal could occur during an ordered protein
oligo- and multimerization process which is what occurs
during aging, aggregation and ¢bril formation. In fact, dra-
matic effects of ordered self-association on the CD of non-
aggregated compounds are known [68^70].
Our EM studies indicated that the species derived by the
end of the conformational transition of ProIAPP under ‘di-
luted’ CD conditions consisted of both ordered but non-
¢brillar species as well as of ¢brils [10,11,42]. The morpho-
logical features of the non-¢brillar, ordered aggregates were
very similar to recently described oligo- and multimeric
structures of other proteins [10,43,44,65], con¢rming pre-
vious suggestions that there might be a common amyloid
formation pathway [71].
The ProIAPP ¢brillar assemblies that formed during the
CD incubations associated laterally into broad sheet-like
assemblies that were reminiscent of the assemblies that
have been previously described for IAPP, AL, and synu-
clein [10,43,65]. Of note, we did not detect the typical
amyloid ¢brillar bundles in the CD solution which had
formed a predominant species when ProIAPP was incu-
bated under ¢brillogenic conditions. Laterally associated
¢brillar assemblies were also the main species present,
when solutions predominantly containing ¢brillar ProIAPP
bundles were diluted up to 100 WM, suggesting that they
might be more stable against dissociation than typical ¢-
brillar bundles. Polymorphism has been described in as-
semblies of IAPP solutions [10]. However, the morpholog-
ical features of ¢brillar assemblies have also been found to
strongly depend on factors such as concentration, buffer,
pH of the solution, properties of the assembly surface, etc.
[43,56,72]. Thus, more studies will be necessary to deter-
mine if there is a relationship between typically observed
ProIAPP ¢brillar bundles and the laterally associated ¢brils.
Unlike for ProIAPP, substantial amounts of typical ¢brillar
bundles were consistently present in CD solutions of aged
IAPP solutions subsequent to the conformational transition
into L-sheets. Importantly, these assemblies were also
present after a 1000-fold dilution of IAPP ¢brillar assem-
blies formed under ¢brillogenic conditions (¢nal IAPP con-
centration of 1 WM), suggesting that they exhibited a mark-
edly higher stability against dissociation than ProIAPP
¢brils.
It should be stressed that the ¢brillar assemblies identi¢ed
following aging in the CD solutions corresponded to spe-
cies formed by aging of the proteins from a denaturated
and disaggregated state (8 M urea), i.e. at the beginning of
this process. Therefore, identi¢cation of such species offers
some information about the kinetic solubilities of the ¢-
brillar assemblies [17]. By contrast, the species found fol-
lowing dilution of aged ¢brillar solutions corresponded to
species whose formation may be related to the dilution-
driven dissociation of the ¢brils. Studies on these species
offer information about the stabilities of the ¢brils against
dissociation.
Together, the EM studies suggested: (1) that ProIAPP has
a lower potential than IAPP to aggregate into typical amy-
loid ¢brillar assemblies although it has a strong potential to
aggregate into ordered oligomeric structures and (2) that
ProIAPP ¢brils are less stable against dissociation than
IAPP ¢brils. The large amounts of amorphous aggregates
seen in the aged CD solutions of mutProIAPP together
with our failure to detect ¢brillar species in diluted ¢brillar
assemblies of mutProIAPP argue: (1) that mutProIAPP has
a strong aggregational propensity to form amorphous aggre-
gates that could be related to its high hydrophobicity and
(2) that mutProIAPP ¢brils have higher kinetic solubility
and lower stability against dissociation than ProIAPP.
These results would thus suggest the following order of
amyloidogenicities: IAPPsProIAPPEmutProIAPP.
A causal direct relationship between amyloid per se and
cell death has yet to be shown. Nevertheless, aged solu-
tions of various amyloidogenic sequences including IAPP
have been found to be cytotoxic to a variety of cell types
[6,7,22,73,74]. In this study, no cytotoxicity was found for
the fusion proteins, a ¢nding that was consistent with the
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observed lack of amyloidogenicity of these proteins. By
contrast, aged IAPP and ProIAPP solutions were cytotoxic,
with ProIAPP being less toxic than IAPP. No cytotoxic
properties were found for mutProIAPP. Of note, both the
observed diminished cytotoxicity and lack of birefringence
of recombinant mutProIAPP were con¢rmed by testing
synthetic mutProIAPP prepared by SPPS methods (to be
published in detail elsewhere).
The morphological features of the species responsible for
amyloid-mediated cell toxicity are not yet de¢ned [56,75].
In particular, there have been indications that both ¢brillar
and non-¢brillar ordered assemblies of amyloid peptides
can cause cytotoxicity [6,74,76]. At the same time, there
is evidence that amorphous aggregates of amyloidogenic
peptides are not cytotoxic [74]. The lower cytotoxicities
and amyloidogenicities found for ProIAPP and mut-
ProIAPP as compared to IAPP would indicate that it is
the ¢brillar assembly form of these proteins that mediates
cytotoxicity. However, our diluted in vitro incubation con-
ditions were not identical to the in situ incubation condi-
tions as performed for the cellular assays, as the latter also
potentially involve cell medium-related effects and phe-
nomena related to a direct protein^cell contact that may
signi¢cantly affect the equilibria of ¢bril formation and
dissolution. Such cell assay-like conditions cannot present-
ly be simulated in vitro. In addition, the altered amyloido-
genicity of mutProIAPP as compared to that of ProIAPP
currently precludes conclusions with regard to the question
of a need for proteolytic processing of ProIAPP to IAPP for
cytotoxicity to occur. More detailed studies are necessary
to address this issue.
The current lack of data of in vivo detectable ProIAPP-
derived amyloid could be consistent with our ¢ndings. The
high self-assembly potential of ProIAPP in combination
with its lower amyloidogenicity as compared to that of
IAPP could result in intracellular storage of the highly am-
yloidogenic IAPP in the form of non-¢brillar ProIAPP ag-
gregates, thus ‘protecting’ the cell from ‘unwanted’ forma-
tion of pancreatic amyloid.
Signi¢cance
IAPP is the major constituent of pancreatic amyloid in type
II diabetes. It has been shown in vitro to exhibit a strong
amyloidogenic and cytotoxic potential. In vivo, IAPP is
stored as ProIAPP in secretory granules and secreted
upon processing in response to insulin secretagogues.
The aim of this study was to evaluate the conformational,
biophysical and potentially amyloidogenic properties of
ProIAPP, and to compare them to the properties of IAPP.
To date, no method has been reported for the synthesis of
ProIAPP. We devised an ef¢cient method for the recombi-
nant generation and puri¢cation of ProIAPP via a non-am-
yloidogenic Trx-His-tagged fusion protein. Under amyloid-
promoting conditions, ProIAPP was found to be capable of
aggregating into typical amyloid ¢brils. Furthermore, a
strong self-associating potential was observed for ProIAPP
which even aggregated at low micromolar concentrations.
Nevertheless, ProIAPP was found to be markedly less am-
yloidogenic than IAPP. While aging of IAPP and other
known amyloidogenic polypeptides occurs via aggregated
L-sheets into typical amyloid ¢brils, aging of ProIAPP was
shown to occur by a distinct conformational transition
which led to mixtures of ¢brils with substantial amounts
of non-¢brillar, yet ordered, oligo- and multimeric aggre-
gates, suggesting that the process of ProIAPP aggregation
and amyloidogenesis is distinguishable from the usually
observed random coil-to-L-sheet transition. Moreover,
aged ProIAPP aggregates were less cytotoxic than those
of IAPP. Cellular storage of proteins including IAPP se-
creted by the ‘regulatory’ pathway is usually achieved in
their aggregated or ‘condensed’ forms. Thus, our studies
would argue for a ‘protective’ role of the pro-region of
ProIAPP against the high amyloidogenic and cytotoxic
properties of IAPP. Protection could be conferred mecha-
nistically by the ability of ProIAPP to self-assemble into
ordered but non-¢brillar aggregates.
Materials and methods
Materials
Synthetic human IAPP was obtained from Calbiochem-Novabiochem
(Bad Soden, Germany). Expression plasmids and host bacteria, His-
Tag resin and recombinant Ek were from Novagen (Madison, WI,
USA). Oligonucleotide primers were acquired from Life Technologies/
Gibco BRL (Eggenstein, Germany). Rabbit polyclonal anti-IAPP anti-
body was from Peninsula Laboratories Europe (Merseyside, UK). Other
molecular biology reagents, cell culture reagents and miscellaneous
chemicals and enzymes were bought from Perkin Elmer-Applied Biosys-
tems (ABI; Weiterstadt, Germany), Novagen, New England Biolabs (Hei-
delberg, Germany), or Sigma-Aldrich Chemicals (Deisenhofen, Ger-
many) and were of the highest grade commercially available.
Cloning of ProIAPP, mutProIAPP and fusion proteins
Human ProIAPP cDNA was prepared from peripheral blood mononu-
clear cells (PBMC) using standard procedures. Brie£y, 2.65U107 PBMC
were isolated by Ficoll gradient centrifugation and total RNA isolated
without further treatment of cells. PreProIAPP cDNA corresponding to
a 270-bp sequence was then ampli¢ed by reverse transcription/polymer-
ase chain reaction (RT/PCR) from 1 Wg RNA employing 35 ampli¢cation
cycles (95³C for 45 s, 50³C for 1 min, 72³C for 45 s). Primers corre-
sponding to the 5P and 3P ends of the human preProIAPP sequence
were 5P-ATG GGC ATC CTG AAG CTG CAA GTA T-3P and 5P-CTA
AAG GGG CAA GTA ATT CAG TGG C-3P. For cloning purposes, the
proIAPP sequence was ampli¢ed from the preProIAPP cDNA template
with the primers 5P-GAG ACC ATG GCT CCC ATT GAA AGT CAT CAG
GTG GAA-3P and 5P-GAG AGC TCA GCC TAA AGG GGC AAG TAA
TTC AGT GG-3P. Primers encompassed the NcoI and BlpI cloning sites,
respectively, for insertion into the pET19b expression vector. PCR con-
ditions for this step were as follows: 30 cycles at 94³C for 45 s, 55³C for
45 s, and 72³C for 30 s. The resulting 159-bp PCR product was then
cloned into pET19b. For construction of the proIAPP^Trx fusion protein
(Trx^ProIAPP), the pET32-LIC-vector system for ligation-independent
cloning (LIC) was used. For ampli¢cation of this construct, primers 5P-
GAC GAC GAC AAG ATC ACA CCC ATT GAA AGT CAT CAG GTG
GA-3P and 5P-GAG GAG AAG CCC GGT CTA AAG GGG CAA GTA
ATT CAG TGG-3P were applied and the PCR performed using the
above protocol. The PCR product was cloned into the pET32-LIC vector
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according to the manufacturer's recommendations. MutProIAPP DNA
was generated by chemical oligonucleotide synthesis of three overlap-
ping primers in combination with two successive PCR reactions. Primers
were designed to span a DNA fragment corresponding to the ProIAPP
cDNA sequence. Primer A included the NcoI cloning site and the N-
terminal cleavage site mutation and primer C included the BlpI cloning
site and the C-terminal cleavage site mutation. In the ¢rst PCR reaction
(35 cycles; 94³C for 45 s, 38³C for 1 min, 72³C for 30 s), primers A and
B were annealed to yield a 5P fragment of 159-bp length containing the
¢rst mutation, i.e. that with the cleavage site between the N-terminal pro-
sequence and IAPP changed. In a second PCR (35 cycles; 94³C for
45 s, 35³C for 1 min, and 72³C for 30 s), the obtained 159-bp fragment
was annealed with primer C and the desired doubly mutated 224-bp
product was ampli¢ed. Primer A was: 5P-CAT GCC ATG GCG CCC
ATT GAA AGT CAT CAG GTG GAA GCG GCG AAA TGC AAC ACT
GCC ACA TGT GCA ACG CAG CGC CTG GCA AAT TTT-3P; primer B
was: 5P-CGC GCC ATA TGT ATT GGA TCC CAC GTT GGT AGA TGA
GAG AAT GGC ACC AAA GTT GTT GCT GGA ATG AAC TAA AAA
ATT TGC CAG GCG C-3P; and primer C was: 5P-AGA CGC TCA GCC
TAA AGG GGC AAG TAA TTC AGT GGC TCT CTC TTT AAA ACC
TCT ACT GCA TTC GCC GCG CCA TAT GTA TTG-3P. Mutated bases
are shown bold and italic. The mutated PCR product was cloned into
pET19b and the pET32-LIC vector as described above for wtProIAPP.
All cloned DNA sequences were con¢rmed by bi-directional sequencing
of at least two independent clones.
Bacterial expression, puri¢cation and characterization of the
fusion proteins
Overexpression of the generated recombinant proteins was performed
in E. coli BL21(DE3)pLys and was induced by IPTG for 3 h. Bacteria
were harvested by centrifugation and cell pellets stored at 380³C. Im-
mediately prior to puri¢cation, cells were thawed and disrupted by a
French Press (1240 psi). As the recombinant proteins formed inclusion
bodies, proteins needed to be solubilized. Various reagents including
different chaotropic agents and detergents were tried. Insoluble protein
was best solubilized by incubation in 20 mM TrisCl buffer, pH 7.9, con-
taining 6 M urea for 2 h at RT. The use of GdnHCl, while equally
ef¢cient at the solubilization step, had adverse effects during the sub-
sequent puri¢cation and renaturation steps (see below).
The His-Tag-containing fusion proteins Trx^ProIAPP and Trx^mut-
ProIAPP were ¢rst puri¢ed by Ni2-chelate af¢nity chromatography fol-
lowing the manufacturer's protocol. All buffers were adjusted to addition-
ally contain 6 M urea. The obtained eluate was further puri¢ed by RP-
HPLC. The following gradient program was applied for all RP-HPLC
puri¢cations performed in this study: step 1: 1 min at 10% buffer B in
buffer A; step 2: 30 min from 10 to 90% buffer B in buffer A, with buffer
A: 0.058% tri£uoroacetic acid (TFA) in H2O and B: 90% acetonitrile,
0.05% TFA in H2O. The HPLC pro¢les of Figures 2D and 3D were
obtained with the above gradient except that step 1 was 2 min in 10%
buffer B in buffer A. The £ow rate was 2 ml/min and detection was at
220 nm. A C18-column (Nucleosil 100 C18, dimensions: 250U8 mm,
particle size 7 Wm and pore size 100 Aî ) (Grom, Herrenberg, Germany)
was used for all protein puri¢cations. The fusion protein fractions were
isolated, lyophilized and kept at 320³C. Identity of the fusion proteins
was con¢rmed by SDS^PAGE (18 or 20% homogeneous gels) using a
previously described method [12] and MALDI-MS or MALDI-TOF-MS
using a Kratos Kompact MALDI III machine (Shimadzu, Duisburg, Ger-
many) or a G2025A LD-TOF-System Mass spectrometer (Hewlett Pack-
ard, Boëblingen, Germany). In addition, immunoblotting analysis with an
anti-IAPP antibody was performed as described [12], showing that both
fusion proteins were detected by the IAPP-speci¢c antibody.
Cleavage of fusion tags, puri¢cation and characterization of
ProIAPP and mutProIAPP
Puri¢ed lyophilized fusion proteins were dissolved in a small volume of
10% acetic acid, neutralized with 10% NH4OH, and diluted with Ek
reaction buffer (Novagen) to a ¢nal protein concentration of about 600
Wg/ml. Eight U/ml of Ek were added and the reaction incubated at RT for
16^20 h. The resulting digests were lyophilized and kept at 320³C until
puri¢cation. For puri¢cation of ProIAPP and mutProIAPP, digests were
dissolved in 10% acetic acid and subjected to RP-HPLC as described
above. Protein-containing fractions were lyophilized immediately and
stored at 320³C. Purity grade and identity were veri¢ed by SDS^
PAGE, HPLC and MS as described above.
In vitro ¢brillation and biophysical methods for ¢bril detection
In vitro ¢brillation of proteins was performed using a 2 mM protein so-
lution in 10% acetic acid essentially as described [12,13]. Brie£y, pro-
teins were incubated for 4 days at RT, solutions neutralized with 10%
NH4OH yielding a 1 mM working solution. The presence of amyloid was
then veri¢ed by CR staining and EM.
The CR staining method for the detection of amyloid ¢brils has been
described [13]. Brie£y, ¢brillated protein solutions were allowed to air-dry
on a glass microscope slide. Staining was performed by the addition of
a saturated CR solution in 80% ethanol. Birefringence was determined
with an Olympus CK40 light microscope (Olympus, Tokyo, Japan) under
polarized light. For EM, 5^10 Wl samples of the protein solutions or
suspensions were applied on carbon-coated copper grids, stained with
uranyl acetate and analyzed as described previously [13] using a Zeiss
EM 109 electron microscope operated at 80 kV.
CD spectropolarimetry
CD spectra were recorded in a J-720 spectropolarimeter (Jasco, Tokyo,
Japan). Cylindrical temperature-controlled quartz cells with a path length
of 10 mm were used in all experiments. CD spectra were recorded at
25³C in the range between 200 and 300 nm at 0.2 nm intervals with a
bandwidth of 1 nm, a scan speed of 50 nm/min, and a time constant of
8.0 s. Protein stock solutions were 500 WM in 10 mM sodium phosphate
buffer, pH 7.4, containing 8 M urea and were usually kept at 320³C.
Under these conditions, denaturated ProIAPP, mutProIAPP, and the
fusion proteins were found to be soluble for several months. IAPP
stocks in 8 M urea were prepared from a 500 WM IAPP stock in HFIP
(kept at 4³C) [13] using the following procedure: an aliquot of the stock
in HFIP was transferred into an Eppendorf tube and HFIP-evaporated at
RT. To the pellet, an appropriate volume of 8 M urea in 10 mM sodium
phosphate, pH 7.4 was added to obtain a 500 WM stock in 8 M urea
which was then placed on ice and used immediately for the CD mea-
surements. For CD measurements, protein stocks that had previously
been thawed on ice, were directly diluted into a buffer-containing cuvette
at RT (except for the IAPP stock which was diluted into the buffer at 4³C
[13]) to give a ¢nal concentration of 5 WM protein (1 WM for the fusion
proteins) in 10 mM sodium phosphate buffer, pH 7.4, containing 0.08 M
urea and spectra were measured immediately or at various time points
thereafter. Temperature denaturation studies were performed at a tem-
perature increase rate of 2³C per min for up to 95³C as described [13].
Thereafter, temperature was decreased at the same rate down to 25³C.
For aging studies, CD spectra were measured at various time intervals
for up to 4^6 days following solution preparation at RT. Thereafter, so-
lutions of ProIAPP and mutProIAPP were centrifuged (5 min at
17 900Ug) and 5^10 Wl phosphate buffer (10 mM sodium phosphate,
pH 7.4) was added to the pellets. Following mixing, solutions were
added onto the EM grid, negatively stained and examined.
CD spectra are presented as a plot of the mean residue ellipticity ([a],
deg cm2 dmol31) versus the wavelength and represent net spectra, with
the spectra of the buffer solution subtracted. CD spectra corresponding
to non-time-dependent measurements represent the average of three
measurements, while spectra corresponding to time-dependent mea-
surements are from one measurement. The CD spectra shown in Figure
6 are representative of two to eight independently performed CD aging
experiments.
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In vitro cytotoxicity studies
The rat insulinoma cell line RIN5fm was obtained from T.E. Rucinsky
from the Washington University Tissue Culture Support Center and was
cultured in RPMI 1640 containing 10% heat-inactivated fetal bovine
serum, 2 mM L-glutamine, 0.1 mM non-essential amino acids, 1 mg/ml
glucose, 1 mM sodium pyruvate and 0.1 mg/ml penicillin/streptomycin.
Cells were plated in 96-well plates at a density of 5U105 cells/ml (100
Wl/well). Following incubation for 24 h (37³C, humidi¢ed atmosphere with
5% CO2), serial dilutions of the aged IAPP, ProIAPP and mutProIAPP
solutions consisting predominantly of ¢brillar aggregates (made with
2 mM protein in 10% HAc; incubation time 4 days as described above)
were made in cell culture medium and 11 Wl added into each well.
Incubations were performed for 20 h and cell viability assessed by mea-
suring the cellular reduction of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-
tetrazolium bromide (MTT) [12].
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